FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4294012493> ?p ?o ?g. }

• W4294012493 abstract "Purpose To identify the most important factors affecting physician decision-making regarding antiplatelet therapy. Methods We retrospectively gathered data from minor ischemic stroke patients with NIHSS scores ≤ 5 within 72 h of onset from 2010 to 2018. The population was divided into four groups by initial antiplatelet therapy: aspirin monotherapy (AM), dual antiplatelet therapy with aspirin and a loading dose of clopidogrel (clopidogrel loading dose of 300 mg on the first day; DAPT-ALC), dual antiplatelet therapy with aspirin and no loading dose of clopidogrel (clopidogrel 75 mg daily, no loading dose; DAPT-AUC), and clopidogrel monotherapy (CM). Results In total, 1,377 patients were included in the analysis (excluding patients who accepted thrombolytic drugs, participated in other clinical trials, or had not used antiplatelet drugs). The mean ± S.D. age was 62.0 ± 12.7 years; 973 (70.7%) patients were male. The four groups were AM ( n = 541, 39.3%), DAPT-ALC ( n = 474, 34.4%), DAPT- AUC ( n = 301, 21.9%), and CM ( n = 61, 4.4%). Patients receiving antiplatelet monotherapy were older than those receiving dual antiplatelet therapy (63.7–65.7 vs. 59.6–61.4 years), and the median initial systolic blood pressure level was higher in the DAPT-ALC group than in the other groups (all P &lt; 0.05). Patients under 75 years old with an admission SBP lower than 180 mmHg, a history of AM, coronary heart disease, no history of intracerebral hemorrhage, stroke onset occurring after guideline recommendations were updated (the year of 2015), onset-to-arrival time within 24 h, and initial NIHSS score ≤ 3 were more likely to take DAPT-ALC than AM. Compared with DAPT-ALC, DAPT-AUC was associated with an initial SBP level lower than 180 mmHg, a history of smoking, hypertension, no history of ICH, previous treatment with antihypertensives, and onset year after the recommendations were updated. Conclusions Many factors affect doctors' decisions regarding antiplatelet therapy, especially guidelines, age, admission SBP level, and hypertensive disease." @default.
• W4294012493 created "2022-09-01" @default.
• W4294012493 creator A5004149275 @default.
• W4294012493 creator A5004727156 @default.
• W4294012493 creator A5023613911 @default.
• W4294012493 creator A5032748496 @default.
• W4294012493 creator A5033747658 @default.
• W4294012493 creator A5039204587 @default.
• W4294012493 creator A5049965759 @default.
• W4294012493 creator A5051183500 @default.
• W4294012493 creator A5064711465 @default.
• W4294012493 creator A5076863688 @default.
• W4294012493 creator A5077265595 @default.
• W4294012493 date "2022-09-01" @default.
• W4294012493 modified "2023-10-04" @default.
• W4294012493 title "Factors affecting physician decision-making regarding antiplatelet therapy in minor ischemic stroke" @default.
• W4294012493 cites W1480729244 @default.
• W4294012493 cites W2067395123 @default.
• W4294012493 cites W2075844793 @default.
• W4294012493 cites W2080670989 @default.
• W4294012493 cites W2081615170 @default.
• W4294012493 cites W2111224949 @default.
• W4294012493 cites W2127366545 @default.
• W4294012493 cites W2138595885 @default.
• W4294012493 cites W2180710707 @default.
• W4294012493 cites W2434322604 @default.
• W4294012493 cites W2464022653 @default.
• W4294012493 cites W2581739005 @default.
• W4294012493 cites W2592988020 @default.
• W4294012493 cites W2616971700 @default.
• W4294012493 cites W2753051611 @default.
• W4294012493 cites W2765476032 @default.
• W4294012493 cites W2799855806 @default.
• W4294012493 cites W2803306216 @default.
• W4294012493 cites W2804570339 @default.
• W4294012493 cites W2940510093 @default.
• W4294012493 cites W2943516261 @default.
• W4294012493 cites W2956957318 @default.
• W4294012493 cites W2963788133 @default.
• W4294012493 cites W2980497811 @default.
• W4294012493 cites W2981784216 @default.
• W4294012493 cites W3011444443 @default.
• W4294012493 cites W3164908038 @default.
• W4294012493 cites W3165784885 @default.
• W4294012493 cites W3184757762 @default.
• W4294012493 cites W3215572056 @default.
• W4294012493 cites W4206710659 @default.
• W4294012493 cites W4285719527 @default.
• W4294012493 cites W4288079168 @default.
• W4294012493 doi "https://doi.org/10.3389/fneur.2022.937417" @default.
• W4294012493 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36119700" @default.
• W4294012493 hasPublicationYear "2022" @default.
• W4294012493 type Work @default.
• W4294012493 citedByCount "2" @default.
• W4294012493 countsByYear W42940124932023 @default.
• W4294012493 crossrefType "journal-article" @default.
• W4294012493 hasAuthorship W4294012493A5004149275 @default.
• W4294012493 hasAuthorship W4294012493A5004727156 @default.
• W4294012493 hasAuthorship W4294012493A5023613911 @default.
• W4294012493 hasAuthorship W4294012493A5032748496 @default.
• W4294012493 hasAuthorship W4294012493A5033747658 @default.
• W4294012493 hasAuthorship W4294012493A5039204587 @default.
• W4294012493 hasAuthorship W4294012493A5049965759 @default.
• W4294012493 hasAuthorship W4294012493A5051183500 @default.
• W4294012493 hasAuthorship W4294012493A5064711465 @default.
• W4294012493 hasAuthorship W4294012493A5076863688 @default.
• W4294012493 hasAuthorship W4294012493A5077265595 @default.
• W4294012493 hasBestOaLocation W42940124931 @default.
• W4294012493 hasConcept C126322002 @default.
• W4294012493 hasConcept C127413603 @default.
• W4294012493 hasConcept C142724271 @default.
• W4294012493 hasConcept C164705383 @default.
• W4294012493 hasConcept C2777628954 @default.
• W4294012493 hasConcept C2777849778 @default.
• W4294012493 hasConcept C2778905298 @default.
• W4294012493 hasConcept C2780007028 @default.
• W4294012493 hasConcept C2780182762 @default.
• W4294012493 hasConcept C2780645631 @default.
• W4294012493 hasConcept C2908647359 @default.
• W4294012493 hasConcept C3020581612 @default.
• W4294012493 hasConcept C71924100 @default.
• W4294012493 hasConcept C78519656 @default.
• W4294012493 hasConcept C99454951 @default.
• W4294012493 hasConceptScore W4294012493C126322002 @default.
• W4294012493 hasConceptScore W4294012493C127413603 @default.
• W4294012493 hasConceptScore W4294012493C142724271 @default.
• W4294012493 hasConceptScore W4294012493C164705383 @default.
• W4294012493 hasConceptScore W4294012493C2777628954 @default.
• W4294012493 hasConceptScore W4294012493C2777849778 @default.
• W4294012493 hasConceptScore W4294012493C2778905298 @default.
• W4294012493 hasConceptScore W4294012493C2780007028 @default.
• W4294012493 hasConceptScore W4294012493C2780182762 @default.
• W4294012493 hasConceptScore W4294012493C2780645631 @default.
• W4294012493 hasConceptScore W4294012493C2908647359 @default.
• W4294012493 hasConceptScore W4294012493C3020581612 @default.
• W4294012493 hasConceptScore W4294012493C71924100 @default.
• W4294012493 hasConceptScore W4294012493C78519656 @default.
• W4294012493 hasConceptScore W4294012493C99454951 @default.
• W4294012493 hasLocation W42940124931 @default.
• W4294012493 hasLocation W42940124932 @default.

• next